Effects of polydatin on attenuating ventricular remodeling in isoproterenol-induced mouse and pressure-overload rat models

Fitoterapia

Volumn 81, Issue 7, 2010, Pages 953-960

  Gao, Jian Ping ^a   Chen, Chang Xun ^a   Gu, Wei Liang ^a   Wu, Qi ^a   Wang, Ying ^a   Lü, Jian ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Blood pressure; Neurohormone; Polydatin; Ventricular remodeling

Indexed keywords

ANGIOTENSIN II; CYCLIC AMP; ENDOTHELIN 1; ISOPRENALINE; NEUROHORMONE; POLYDATIN; POLYGONUM CUSPIDATUM EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; HEART MUSCLE CELL; HEART VENTRICLE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; BLOOD PRESSURE; CARDIOVASCULAR AGENTS; COLLAGEN; CYCLIC AMP; DRUGS, CHINESE HERBAL; ENDOTHELIN-1; GLUCOSIDES; HEART; HYPERTROPHY, LEFT VENTRICULAR; ISOPROTERENOL; MALE; MICE; MYOCYTES, CARDIAC; ORGAN SIZE; PHYTOTHERAPY; POLYGONUM CUSPIDATUM; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

MUS; RATTUS;

EID: 77956702315     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2010.06.023     Document Type: Article

References (42)

1. A. Ganau, R.B. Devereux, T.G. Pickering, M.J. Roman, P.L. Schnall, and S. Santucci Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension Circulation 81 1 1990 25 36
2. G. Schillaci, P. Verdecchia, C. Porcellati, O. Cuccurullo, C. Cosco, and F. Perticone Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension Hypertension 35 2 2000 580 586
3. Y.N. Wang, Y.H. Wei, H.Y. Hao, and J.Y. Ji Advances in the research of resveratrol metabolins Acta Boreal.-Occident Sin 27 4 2007 0852 0857
4. S.F. Luo, C.L. Yu, and P.W. Zhang Influences of 3, 4, 5- trihydroxystibene-3-β-mono-D-glucoside on beat rate and injury of cultured newborn rat myocardial cells Zhongguo Yao Li Xue Bao 11 2 1990 147 150
5. Q. Zhao, H.X. Huang, and C.H. Jin Protective effect of polydatin against lipopolysaccharide-induced myocardial injury Di Yi Jun Yi Da Xue Xue Bao 23 4 2003 364 366
6. L.P. Zhang, C.Y. Yang, Y.P. Wang, F. Cui, and Y. Zhang Protective effect of polydatin against ischemia/reperfusion injury in rat heart Sheng Li Xue Bao 60 2 2008 161 168
7. L.P. Zhang, H.J. Ma, H.M. Bu, M.L. Wang, Q. Li, and Z. Qi Polydatin attenuates ischemia/reperfusion-induced apoptosis in myocardium of the rat Sheng Li Xue Bao 61 4 2009 367 372
8. K.S. Zhao, C. Jin, X. Huang, J. Liu, W.S. Yan, and Q. Huang The mechanism of polydatin in shock treatment Clin Hemorheol Microcirc 29 3-4 2003 211 217
9. K.S. Zhao Hemorheologic events in severe shock Biorheology 42 6 2005 463 477
10. Y.Z. Wang, S.F. Luo, P.W. Zhang, and C.L. Yu Reducing effect of 3, 4', 5-trihydroxystibene-3-beta-mono-D-glucoside on arterial thrombosis induced by vascular endothelial injury Zhongguo Yao Li Xue Bao 16 2 1995 159 162
11. P.W. Zhang, C.L. Yu, Y.Z. Wang, S.F. Luo, L.S. Sun, and R.S. Li Influence of 3, 4', 5-trihydroxystibene- 3-beta -mono-D-glucoside on vascular endothelial epoprostenol and platelet aggregation Zhongguo Yao Li Xue Bao 16 3 1995 265 268
12. S.Y. Shu, X.Y. Wang, Z.Y. Ling, and Z.Y. Lu Effect of polydatin on phospholipase A2 in lung tissues in rats with endotoxic shock Chin J Traumatol 7 4 2004 239 243
13. W.W. Xing, J.Z. Wu, M. Jia, J. Du, H. Zhang, and L.P. Qin Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits Biomed Pharmacother 63 7 2009 457 462
14. Y. Cheng, H.T. Zhang, L. Sun, S. Guo, S. Ouyang, and Y. Zhang Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury Brain Res 1110 1 2006 193 200
15. H.X. Huang, Q. Zhao, and C.H. Jin Effect of polydatin on lipopolysaccharide-induced leucocyte chemotaxis Di Yi Jun Yi Da Xue Xue Bao 23 12 2003 1253 1256
16. C.G. Brilla, G.P. Reams, B. Maisch, and K.T. Weber Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix Eur Heart J 14 1993 57 61 Suppl J
17. W.J. Remme Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy Cardiovasc Drugs Ther 17 4 2003 349 360
18. B. Swynghedauw Molecular mechanisms of myocardial remodeling Physiol Rev 79 1 1999 215 262
19. K. Ji, M. Minakawa, K. Fukui, Y. Suzuki, and I. Fukuda Increased superoxide radical with a decrease in vascular endothelial growth factor and inducible nitric oxide synthase level leads to the progression of left ventricular hypertrophy in a pressure-overload rat heart model Ann Thorac Cardiovasc Surg 14 4 2008 210 217
20. A.R. Hohimer, L.E. Davis, and D.C. Hatton Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure Can J Physiol Pharmacol 83 2 2005 191 197
21. J.M. Krzesinski, G. Rorive, and H. Van Cauwenberge Hypertension and left ventricular hypertrophy Acta Cardiol 51 2 1996 143 154
22. K.T. Weber, and C.G. Brilla Pathological hypertrophy and cardiac interstitium. Fibrosis and rennin-angiotensin-aldosterne system Circulation 83 6 1991 1849 1965
23. M.H. Drazner The transition from hypertrophy to failure: how certain are we? Circulation 112 7 2005 936 938
24. J.J. Mercadier Current pathophysiologic approaches to heart failure Presse Méd 36 6 Pt 2 2007 979 984
25. M.R. Weir, and V.J. Dzau The renin-angiotensin-aldosterone system: a specific target for hypertension management Am J Hypertens 12 12 Pt 3 1999 205S 213S
26. D.A. Duprez Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review J Hypertens 24 6 2006 983 991
27. J.N. Cohn, and W. Colucci Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology Am J Cardiol 97 10A 2006 4F 12F
28. K.F. Adams Jr. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure Am J Health Syst Pharm 61 Suppl 2 2004 S4 S13
29. J. Szabó, L. Csáky, and J. Szegi Experimental cardiac hypertrophy induced by isoproterenol in the rat Acta Physiol Acad Sci Hung 46 3 1975 281 285
30. C. Morisco, D.C. Zebrowski, D.E. Vatner, S.F. Vatner, and J. Sadoshima Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart J Mol Cell Cardiol 33 3 2001 561 573
31. L. Slǎtineanu, V. Aursulesei, A. Petriş, G. Datcu, and M.D. Datcu Correlation between plasma level of endothelin-1 and heart remodeling in dilated cardiomyopathy Rev Med Chir Soc Med Nat Iasi 111 2 2007 345 351
32. T. Kinugawa, M. Kato, K. Ogino, S. Osaki, O. Igawa, and I. Hisatome Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure J Card Fail 9 4 2003 318 324
33. Z. Kassiri, G.Y. Oudit, O. Sanchez, F. Dawood, F.F. Mohammed, and R.K. Nuttall Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice Circ Res 97 4 2005 380 390
34. M. Sun, M. Chen, F. Dawood, U. Zurawska, J.Y. Li, and T. Parker Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state Circulation 115 11 2007 1398 1407
35. M. Negrusz-Kawecka The role of TNF-alpha in the etiopathogenesis of heart failure Pol Merkur Lek 12 67 2002 69 72
36. C. Henry-Vitrac, A. Desmoulière, D. Girard, and J.M. Mérillon Krisa S Transport, deglycosylation, and metabolism of trans-piceid by small intestinal epithelial cells Eur J Nutr 45 7 2006 376 382
37. M.J. Zhou, X.Y. Chen, and D.F. Zhong Metabolism of trans-resveratrol-3-O- glucoside in vitro in rat tissues Yao Xue Xue Bao 42 5 2007 520 524
38. G. Kuhnle, J.P. Spencer, G. Chowrimootoo, H. Schroeter, E.S. Debnam, and S.K. Srai Resveratrol is absorbed in the small intestine as resveratrol glucuronide Biochem Biophys Res Commun 272 1 2000 212 217
39. M. Zhou, X. Chen, and D. Zhong Simultaneous determination of trans-resveratrol-3-O-glucoside and its two metabolites in rat plasma using liquid chromatography with ultraviolet detection J Chromatogr B Analyt Technol Biomed Life Sci 854 1-2 2007 219 223
40. A. Biala, E. Tauriainen, A. Siltanen, J. Shi, S. Merasto, and M. Louhelainen Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes Blood Press 19 3 2010 196 205
41. P. Wojciechowski, D. Juric, X.L. Louis, S.J. Thandapilly, L. Yu, and C. Taylor Resveratrol arrests and regresses the development of pressure overload - but not volume overload-induced cardiac hypertrophy in rats J Nutr 140 5 2010 962 968
42. S.J. Thandapilly, P. Wojciechowski, J. Behbahani, X.L. Louis, L. Yu, and D. Juric Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure Am J Hypertens 23 2 2010 192 196